Showing results (51-60 of 436) with videos related to
Sort By:
Pageof 44
Arthritis and Rheumatism|January 1, 2009
Identification of relevant concepts of functioning in daily life in people with systemic lupus erythematosus: A patient Delphi exerciseBettina Bauernfeind, Martin Aringer, Birgit Prodinger, et al.Inflammatory Bowel Diseases|April 4, 2014
AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn's disease: FHAST-1, a phase 3, multicenter, placebo-controlled studyWalter Reinisch, Simon Travis, Stephen Hanauer, et al.Inflammatory Bowel Diseases|January 13, 2017
The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel DiseaseJames D Lewis, Lindsey Albenberg, Dale Lee, et al.Crohn'S & Colitis 360|September 11, 2023
Low Occurrence of Colectomy With Long-Term (up to 4 Years) Golimumab Treatment in Patients With Moderate-to-Severe Active Ulcerative Colitis: Data From the PURSUIT Maintenance and Long-Term Extension StudiesCindy L J Weinstein, Alan G Meehan, Marinella Govoni, et al.Journal of Clinical Pharmacology|September 9, 2020
Increased Induction Infliximab Clearance Predicts Early Antidrug Antibody DetectionAlexander Eser, Walter Reinisch, Stefan Schreiber, et al.European Journal of Gastroenterology & Hepatology|September 27, 2022
Pilot study of an elimination diet in adults with mild to moderate Crohn's diseaseNeeraj Narula, Emily C L Wong, Paul Moayyedi, et al.Arthritis Research & Therapy|November 12, 2019
Disease activity improvements with optimal discriminatory ability between treatment arms: applicability in early and established rheumatoid arthritis clinical trialsJosef Smolen, Roy Fleischmann, Daniel Aletaha, et al.Journal of Crohn'S & Colitis|December 22, 2010
Public awareness of Crohn's disease and ulcerative colitis: A national surveySieglinde Angelberger, Harald Vogelsang, Gottfried Novacek, et al.Scandinavian Journal of Gastroenterology|July 27, 2021
Role of fecal calprotection in predicting endoscopic recurrence in postoperative Crohn's diseaseChristian Primas, Gertrud Hopf, Sieglinde Reinisch, et al.Journal of Clinical Medicine|June 24, 2022
Model Informed Precision Dosing Tool Forecasts Trough Infliximab and Associates with Disease Status and Tumor Necrosis Factor-Alpha Levels of Inflammatory Bowel DiseasesChristian Primas, Walter Reinisch, John C Panetta, et al.Pageof 44